Abstract
Purpose: This is a phase II multicenter, single-arm, open-label study assessing the efficacy, safety, and pharmacokinetics (PK) of ripretinib in Chine......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
